Putnam Investments LLC Vericel Corp Transaction History

Putnam Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$30.93 - $59.48 $3.98 Million - $7.66 Million	-128,785 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $262,940 - $446,985	-14,190 Reduced 9.92%	128,785 $3.98 Million
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $6,621 - $12,323	779 Added 0.55%	142,975 $1.98 Million
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $6,742 - $17,874	-930 Reduced 0.65%	142,196 $1.3 Million
Q3 2019 Nov 14, 2019	BUY	$14.93 - $19.83 $4,926 - $6,543	330 Added 0.23%	143,126 $2.17 Million
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $291,117 - $363,941	17,937 Added 14.37%	142,796 $2.5 Million
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $44,910 - $76,894	4,170 Added 3.46%	124,859 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $508,544 - $827,083	55,884 Added 86.23%	120,689 $1.71 Million
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $622,128 - $946,153	64,805 New	64,805 $628,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.